Article
The L-, N-, and T-type triple calcium channel blocker benidipine acts as an antagonist of mineralocorticoid receptor, a member of nuclear receptor family.
European journal of pharmacology - 10 Jun 2010
Kosaka Hiromichi, Hirayama Kazunori, Yoda Nobuyuki, Sasaki Katsutoshi, Kitayama Tetsuya, Kusaka Hideaki, Matsubara Masahiro
Abstract excerpt
Aldosterone-induced activation of mineralocorticoid receptor, a member of the nuclear receptor family, results in increased tissue damage such as vascular inflammation and cardiac and perivascular fibrosis. Benidipine, a long-lasting dihydropyridine calcium channel blocker, is used for hypertension and angina. Benidipine exhibits pleiotropic pharmacological features such as renoprotective and cardioprotective...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
